Soleno Therapeutics (NASDAQ:SLNO) Price Target Raised to $65.00
Soleno Therapeutics (NASDAQ:SLNO – Get Free Report) had its target price upped by equities researchers at Oppenheimer from $59.00 to $65.00 in a note issued to investors on Monday, Benzinga reports. The firm presently has an “outperform” rating on the stock. Oppenheimer’s target price would indicate a potential upside of 31.26% from the company’s current […]
More Stories
900 Visas Revoked in Birth Tourism Crackdown: State Department
By Jack Phillips The U.S. Department of State on Aug. 20 said that nearly 900 visas have been revoked since...
A Man on the Inside: Release Date, Trailer, Plot, and Episode Updates
Is your favourite detective, Ted Danson, returning with a season 3 of A Man on the Inside? Fans are looking...
8 Killed After Charter Plane Crashes in Western Alaska: US Military
By AldgraFredly The U.S. military said on Aug. 20 that eight people were killed after a charter plane crashed at...
Israel, Turkey Continue Dispute Over Syria After Airbase Strike
By Evgenia Filimianova Israel and Turkey have deepened their dispute over Syria after Israel defended its strike on a Syrian...
First Lady Unveils Racing Collaboration, $2 Million in ‘Fostering the Future’ Scholarships
By Travis Gillmore WASHINGTON—First Lady Melania Trump held her first public event in about two months at the White House...
US Unemployment Claims Unexpectedly Dropped Last Week
By Andrew Moran The number of Americans submitting applications for unemployment benefits unexpectedly declined last week for the first time...